MX2019011064A - Metodos para usar marcadores geneticos asociados con endometriosis. - Google Patents

Metodos para usar marcadores geneticos asociados con endometriosis.

Info

Publication number
MX2019011064A
MX2019011064A MX2019011064A MX2019011064A MX2019011064A MX 2019011064 A MX2019011064 A MX 2019011064A MX 2019011064 A MX2019011064 A MX 2019011064A MX 2019011064 A MX2019011064 A MX 2019011064A MX 2019011064 A MX2019011064 A MX 2019011064A
Authority
MX
Mexico
Prior art keywords
endometriosis
methods
genetic markers
markers associated
symptom
Prior art date
Application number
MX2019011064A
Other languages
English (en)
Inventor
Ward Kenneth
N Chettier Rakesh
M Albertsen Hans
Original Assignee
Juneau Biosciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Juneau Biosciences Llc filed Critical Juneau Biosciences Llc
Publication of MX2019011064A publication Critical patent/MX2019011064A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Abstract

Se describen en la presente métodos para usar marcadores genéticos asociados con endometriosis, por ejemplo a través de un programa implementado por computadora para predecir el riesgo de desarrollar endometriosis, y métodos para prevenir o tratar endometriosis o un síntoma de la misma.
MX2019011064A 2017-03-15 2018-03-15 Metodos para usar marcadores geneticos asociados con endometriosis. MX2019011064A (es)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201762471462P 2017-03-15 2017-03-15
US201762471448P 2017-03-15 2017-03-15
US201762471457P 2017-03-15 2017-03-15
US201762508379P 2017-05-18 2017-05-18
US201762588265P 2017-11-17 2017-11-17
US201762588268P 2017-11-17 2017-11-17
US201862639711P 2018-03-07 2018-03-07
US201862639730P 2018-03-07 2018-03-07
PCT/US2018/022743 WO2018170325A1 (en) 2017-03-15 2018-03-15 Methods of using genetic markers associated with endometriosis

Publications (1)

Publication Number Publication Date
MX2019011064A true MX2019011064A (es) 2020-01-27

Family

ID=63522597

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019011064A MX2019011064A (es) 2017-03-15 2018-03-15 Metodos para usar marcadores geneticos asociados con endometriosis.

Country Status (7)

Country Link
US (1) US20210115513A1 (es)
EP (1) EP3596100A4 (es)
CN (1) CN110914455A (es)
CA (1) CA3057613A1 (es)
IL (1) IL269339A (es)
MX (1) MX2019011064A (es)
WO (1) WO2018170325A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010124101A2 (en) 2009-04-22 2010-10-28 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
EP3847182A4 (en) * 2018-09-07 2022-06-29 Juneau Biosciences, L.L.C. Methods of using genetic markers associated with endometriosis

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833529B1 (en) * 1999-01-07 2010-11-16 Zymogenetics, Inc. Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
ATE437227T1 (de) * 1999-01-07 2009-08-15 Zymogenetics Inc Verfahren zur therapeutischen verwendung von löslichen rezeptoren br43x2
BRPI0713000A8 (pt) * 2006-06-12 2017-12-05 Trubion Pharmaceuticals Inc Proteína de ligação multiespecífica de cadeia simples, composição farmacêutica e uso da referida proteína de ligação multiespecífica de cadeia simples
EP2118321A4 (en) * 2007-02-06 2010-06-30 Genizon Biosciences GENCARTS OF HUMAN GENES ASSOCIATED WITH ENDOMETRIOSIS
US20080305967A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Genetic Markers Associated with Endometriosis and Use Thereof
US8932993B1 (en) * 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
US20150361494A1 (en) * 2010-03-26 2015-12-17 Juneau Biosciences, Llc Genetic Markers Associated with Endometriosis and Use Thereof
CA2695374A1 (en) * 2007-08-15 2009-02-19 Amunix, Inc. Compositions and methods for modifying properties of biologically active polypeptides
US20140024590A1 (en) * 2011-02-18 2014-01-23 Yale University KRAS-Variant And Endometriosis
CA2850930A1 (en) * 2011-10-03 2013-04-11 Celmatix, Inc. Methods and devices for assessing risk to a putative offspring of developing a condition
KR20150043566A (ko) * 2012-09-12 2015-04-22 버그 엘엘씨 심장독성 약제의 동정에 마커를 사용하는 용도
US9434991B2 (en) * 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
US10877045B2 (en) * 2015-07-21 2020-12-29 Saint Louis University Compositions and methods for diagnosing and treating endometriosis-related infertility

Also Published As

Publication number Publication date
CA3057613A1 (en) 2018-09-20
WO2018170325A1 (en) 2018-09-20
CN110914455A (zh) 2020-03-24
EP3596100A4 (en) 2021-01-13
IL269339A (en) 2019-11-28
US20210115513A1 (en) 2021-04-22
EP3596100A1 (en) 2020-01-22

Similar Documents

Publication Publication Date Title
MX2022006260A (es) Compuestos, composiciones y metodos para el tratamiento de enfermedades.
GB2552605A (en) Enhancing functionalities of virtual assistants and dialog systems via plugin marketplace
MX2018010362A (es) Metodos y sistemas para evaluar carga mutacional de tumores.
MX2017000857A (es) Combinación de un antagonista de la proteina de muerte programada (pd-1) y una vacuna basada en listeria para tratar el cáncer de próstata.
EA201691376A1 (ru) Комбинация антагониста pd-1 и ингибитора vegfr для лечения рака
EA201792545A1 (ru) Способы и наборы для лечения депрессии
MX2021006626A (es) Marcadores geneticos para predecir la reactividad a terapia con agente que eleva la lipoproteina de alta densidad (hdl) o que imita la lipoproteina de alta densidad (hdl).
GB2570089A (en) Geomechanical risk and hazard assessment and mitigation
MX2019000088A (es) Composiciones y metodos para detectar y tratar la diabetes.
CR20160132A (es) Composiciones y método para tratar condiciones asociadas con el complemento
PH12018502020A1 (en) Methods for treating and preventing c. difficile infection
GB2548999A (en) Multi-stage treatment for iron sulfide scales
PH12020551663A1 (en) Genetic loci associated with increased fertility in maize
CL2020002468A1 (es) Anticuerpos que se unen a la sortilina e inhiben la union de progranulina.(divisional de solicitud 92-2018)
MX2020006297A (es) Variantes de cd19.
PH12018501650A1 (en) Regulation of gene expression through aptamer-modulated polyadenylation
SG11202004766SA (en) Method and system for a value based attestation of counterparty credibility
MX2019011064A (es) Metodos para usar marcadores geneticos asociados con endometriosis.
MX367829B (es) Métodos para mejoramiento de plantas.
MX2019009304A (es) Tratamiento para el cancer.
MY193347A (en) Mantle phenotype detection in palm
TR201907044T4 (tr) Yeni bileşikler.
TR201906862T4 (tr) Yüksek fırının çalıştırılmasına yönelik yöntem.
MX2022008274A (es) Metodos para tratar trastornos de hiperpigmentacion.
MX2023008764A (es) Composiciones y metodos para prevenir y tratar afecciones.